Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Palmoplantar Psoriasis”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Post-approval studies (Phase 4)Looking for participantsNCT07503652
What this trial is testing

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
First Hospital of China Medical University 10
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Large-scale testing (Phase 3)Study completedNCT04713592
What this trial is testing

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement

Who this might be right for
Psoriasis
AbbVie 174
Large-scale testing (Phase 3)Study completedNCT01806597
What this trial is testing

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

Who this might be right for
Moderate to Severe Palmoplantar Psoriasis
Novartis Pharmaceuticals 205
Not applicableNot Yet RecruitingNCT06802848
What this trial is testing

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

Who this might be right for
Plaque PsoriasisPsoriatic ArthritisScalp Psoriasis+3 more
Chongqing Genrix Biopharmaceutical Co., Ltd 1,000
Testing effectiveness (Phase 2)Study completedNCT04572997
What this trial is testing

Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)

Who this might be right for
Palmoplantar Pustulosis
Kristian Reich 21
Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Testing effectiveness (Phase 2)Study completedNCT00585650
What this trial is testing

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

Who this might be right for
Psoriasis
University of California, Irvine 20
Large-scale testing (Phase 3)Study completedNCT02008890
What this trial is testing

Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab

Who this might be right for
Palmoplantar Pustular Psoriasis
Novartis Pharmaceuticals 237
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367
What this trial is testing

A Phase III Randomized Controlled Trial Evaluating the Efficacy and Safety of Tofacitinib Combined With Imatinib in Patients With Moderate-to-Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Second Affiliated Hospital, School of Medicine, Zhejiang University 135